Browsing by Author Benetatos, L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 16 of 16
TitleAuthor(s)Issue date
The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasmsHatzimichael, E.; Dasoula, A.; Benetatos, L.; Makis, A.; Stebbing, J.; Crook, T.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaHatzimichael, E.; Benetatos, L.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Georgiou, I.; Syrrou, M.; Stebbing, J.; Coley, H. M.; Crook, T.; Bourantas, K. L.24-Nov-2015
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implicationsHatzimichael, E.; Dasoula, A.; Kounnis, V.; Benetatos, L.; Nigro, C. L.; Lattanzio, L.; Papoudou-Bai, A.; Dranitsaris, G.; Briasoulis, E.; Crook, T.24-Nov-2015
Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosisBenetatos, L.; Chaidos, A.; Alymara, V.; Vassou, A.; Bourantas, K. L.24-Nov-2015
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromesBenetatos, L.; Hatzimichael, E.; Dasoula, A.; Dranitsaris, G.; Tsiara, S.; Syrrou, M.; Georgiou, I.; Bourantas, K. L.24-Nov-2015
Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patientBenetatos, L.; Hatzimichael, E.; Vassou, A.; Bourantas, K. L.24-Nov-2015
Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpuraBenetatos, L.; Vassou, A.; Bourantas, K. L.24-Nov-2015
Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literatureBenetatos, L.; Alymara, V.; Vassou, A.; Bourantas, K. L.24-Nov-2015
Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromesBenetatos, L.; Dasoula, A.; Syed, N.; Hatzimichael, E.; Crook, T.; Bourantas, K. L.24-Nov-2015
Non-secretory multiple myeloma with involvement of the hand as initial manifestationBenetatos, L.; Alymara, V.; Chaidos, A.; Vassou, A.; Bourantas, K. L.24-Nov-2015
Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive useBenetatos, L.; Dova, L.; Baxevanos, G.; Kolaitis, N. I.; Bourantas, K. L.; Vartholomatos, G.24-Nov-2015
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactionsBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Syed, N.; Voukelatou, M.; Dranitsaris, G.; Bourantas, K. L.; Crook, T.24-Nov-2015
Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myelomaBenetatos, L.; Dasoula, A.; Hatzimichael, E.; Georgiou, I.; Syrrou, M.; Bourantas, K. L.24-Nov-2015
Rituximab as first line treatment for MALT lymphoma of extraocular musclesBenetatos, L.; Alymara, V.; Asproudis, I.; Bourantas, K. L.24-Nov-2015
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim supportHatzimichael, E.; Benetatos, L.; Stebbing, J.; Kapsali, E.; Panayiotopoulou, S.; Bourantas, K. L.24-Nov-2015
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseHatzimichael, E.; Dranitsaris, G.; Dasoula, A.; Benetatos, L.; Stebbing, J.; Crook, T.; Bourantas, K. L.24-Nov-2015